Allyx Therapeutics Inc.

New Haven, CT

UEI
J1EHDFKTPBS7
CAGE
8CMV8
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
555 Long Wharf Dr #111, New Haven, CT 06511, USA
Website
allyxthera.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Allyx Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Clinical evaluation of BMS-984923 metabolism. - summary/abstract this project seeks to develop a novel disease-modifying… Grant · SB1AG087748 National Institute on Aging $5,026,306
BMS-984923 non-clinical development to support phase 2 trials - summary/abstract this project seeks to develop a novel… Grant · R44AG077984 National Institute on Aging $2,699,967

Quick answers

What is Allyx Therapeutics Inc.'s UEI?

Allyx Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is J1EHDFKTPBS7.

What is Allyx Therapeutics Inc.'s CAGE code?

Allyx Therapeutics Inc.'s CAGE code is 8CMV8.

What is Allyx Therapeutics Inc.'s primary NAICS code?

Allyx Therapeutics Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Allyx Therapeutics Inc. located?

Allyx Therapeutics Inc.'s physical address in SAM.gov is 555 Long Wharf Dr #111, New Haven, CT 06511, USA.

Is Allyx Therapeutics Inc. registered in SAM.gov?

Yes. Allyx Therapeutics Inc.'s SAM.gov registration is active through January 6, 2027.

What is Allyx Therapeutics Inc.'s most recent federal award?

Allyx Therapeutics Inc.'s most recent federal grant award is Clinical evaluation of BMS-984923 metabolism. - summary/abstract this project seeks to develop a novel disease-modifying… (SB1AG087748), from National Institute on Aging, on September 20, 2024.

On GovTribe

See Allyx Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login